Phase 2 clinical trial of cridanimob (Virexxa) for treatment of advanced and recurrent endometrial cancer in the EU
Latest Information Update: 19 Jul 2013
At a glance
- Drugs Cridanimod (Primary)
- Indications Endometrial cancer
- Focus Therapeutic Use
- 19 Jul 2013 New trial record